Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. - Wikidata - wikimedia - TriplyDB

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

http://www.wikidata.org/entity/Q38050959

about

In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome.Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors.Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome Childhood Nephrotic Syndrome Management and Outcome: A Single Center Retrospective Analysis.Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date.Interventions for idiopathic steroid-resistant nephrotic syndrome in children.Benign acute childhood myositis complicating influenza B infection in a boy with idiopathic nephrotic syndrome.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome.Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.Tuberculosis infection in children with proteinuria/nephrotic syndrome.Ofatumumab for the treatment of childhood nephrotic syndrome.Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.Neurotoxicity of cyclosporine A in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage?Monogenic Causes of Proteinuria in Children.Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.Rho-GTPase Signalling in the Pathogenesis of Nephrotic Syndrome

P2860

Q34519514-EA25087D-F89F-4D4F-B3E3-51926D337384 Q35576147-9E755B4E-F75B-48BF-A319-3A416578D1E2 Q35712990-AB01130A-25A8-410F-865B-F7F0F6A70C67 Q36322955-1C94F4E6-EBA8-4DFF-9FF5-B40F22A350CB Q36543103-A006A230-5242-4B82-ABA8-13009A002067 Q37689858-D54E47FD-9408-4937-AD98-8927191EE235 Q38050961-43EC1C3D-0A3A-4D07-A864-EBA0F3751C52 Q38132611-1BF56FE6-BAE5-4BEA-89B2-D4055CB01D84 Q38662074-E51073E2-22E8-4983-AFA3-044E87E1E6E0 Q38801673-00FF7B44-927A-41FB-A021-ED139B1D091E Q40080445-CF336D8B-99FE-4AAF-985A-354C3E7330C6 Q40193019-4E8664A5-51DA-4A33-BB97-79330118A60A Q40775615-C0EFCEFA-7345-4CEC-88E0-87CF19785548 Q41027140-0549FB64-C0D7-45A9-BF0F-90D05619C580 Q41602217-3DFB9B64-14BD-45E3-AAE8-CA35F3582B94 Q42372585-F2350B0A-393B-4A7B-9BEF-45E8ADBC0951 Q43805398-73DEFD42-0A1E-4D8B-B4C0-7BD4985C0B05 Q44410073-24E1EC4F-E253-48F3-BC24-206DEBF46F55 Q47097995-12A45C79-029F-492F-B8E1-22641C0384F4 Q48221532-F2034AA0-D63D-460F-82AC-BF878B02CBF5 Q50100678-401F7FC5-AF17-46FB-8854-08735BDE9984 Q52091884-2F4A13B1-9339-469B-9F84-2B66BEF8CF07 Q52723397-9BA52435-F324-4C1C-9537-81B9BB16592C Q53637511-7FE323DA-23A1-4FCC-BC13-2D51040C8821 Q59052275-5EC6763A-C882-43C0-A08E-5B0D3A90D870

P2860

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

http://www.wikidata.org/entity/Q38050959

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

@en

type

label

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

@en

prefLabel

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

@en

P1433

Q38050959-52ABDB91-5D38-4062-8DA4-D797A5F6266D

P1476

Q38050959-716B0AF9-CFF5-4E81-89CC-A70C197FABCB

P2093

Q38050959-3AEAD5F7-29E1-4A48-8E26-71E467BD6DF6

Q38050959-3E94731E-98F8-43B7-982E-CCF20C16B7E9

Q38050959-621EE83A-784F-4154-9E97-83EEF4EE5653

P2860

Q38050959-00F250C3-3D57-44CF-9E8A-F2C7EBC84CE2

Q38050959-03913C00-D5D4-4404-8E0C-CB31968A202A

Q38050959-05CCFF47-933A-4D3B-BC1F-1B96BB0A1B0B

Q38050959-0E97FCE1-7457-4C44-B94F-2E4C94F9E1D4

Q38050959-11AFDCC8-6675-4BA1-B56E-886B8F5D3870

Q38050959-1AB8011D-F891-482F-B169-8ACD6A265265

Q38050959-20739E22-F7DA-418B-9138-AB6038E73B00

Q38050959-321D9C8C-CBB5-4803-AC44-88F46ABC0849

Q38050959-494F9F24-F9BB-4C4B-977D-2CD03AA4AB10

Q38050959-4C95DDAA-9454-42DB-B583-CF8D2C967434

P2888

Q38050959-1860DF5B-AB07-4953-8F4F-8A0AAA21AF4F

P304

Q38050959-0826DB1B-F7DE-4872-9B97-35D7421F476A

P31

Q38050959-E18EEE1B-9E18-4EDE-82F8-EF8F709AE0FB

P356

Q38050959-99A11714-8A96-4D2F-AB52-1A9608B8BA78

P433

Q38050959-EC9D6C66-E4D7-4470-ACE8-130ACE39DB9A

P478

Q38050959-811C5DD9-6A3C-4CF9-9AED-D7AFEBEB0D47

P50

Q38050959-FB1BD8CF-F193-4F13-9D5A-923E3A448698

P577

Q38050959-5915914F-E8AD-4495-9EFC-B516A06C31F3

P5875

Q38050959-438F37EC-5DF2-4105-865E-44EAC742A672

P6179

Q38050959-BCFAE24E-4406-4715-B0E2-62288000CBFF

P698

Q38050959-7C8387D2-9AA3-4240-80FB-9963900BF4ED

P356

S00467-012-2304-8

P1433

Pediatric Nephrology

P1476

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

@en

P2093

Elisabeth M Hodson

http://www.w3.org/2001/XMLSchema#string

Kidney Disease: Improving Global Outcomes

http://www.w3.org/2001/XMLSchema#string

Rebecca M Lombel

http://www.w3.org/2001/XMLSchema#string

P2860

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome.

Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report.

NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.

Enalapril dosage in steroid-resistant nephrotic syndrome.

Clinical trial of focal segmental glomerulosclerosis in children and young adults.

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

P2888

s00467-012-2304-8

P304

409-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-012-2304-8

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Debbie S Gipson

P577

2012-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232229355

http://www.w3.org/2001/XMLSchema#string

P6179

1043172470

http://www.w3.org/2001/XMLSchema#string

P698

23052648

http://www.w3.org/2001/XMLSchema#string